Companies: 10,795·Total market cap: $144.5T
Savara Inc.

Savara Inc.

SVRANASDAQHealthcare● Active
$5.20
+$0.11(+2.06%)
Market Cap$1.1B
P/E Ratio—
52W High$7.005
52W Low$1.98
SEC Filings

Savara Inc. (SVRA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001160308 · SVRA · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
10-Q
Latest Form
2026-05-12
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001160308 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-13
Fiscal Year End
Mar 13, 2026
Accession No.
0001193125-26-105076
Primary Document
svra-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001160308 · Accession 0001193125-26-105076

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
View 10-Q on SEC
8-KCurrent Report
8-K
2026-03-13Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-12
View
ARSARS
ARS
2026-04-24
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-24
View
DEF 14AProxy Statement
DEF 14A
2026-04-24
View
PRE 14APRE 14A
PRE 14A
2026-04-10
View
8-KCurrent Report
8-K
2026-03-13
View
10-KAnnual Report
10-K
2026-03-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-05
View
8-KCurrent Report
8-K
2026-01-27
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-01-21
View
8-KCurrent Report
8-K
2026-01-09
View
Showing 1–15 of 699 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001160308  |  Exchange: NASDAQ · Healthcare

Savara Inc. (NASDAQ: SVRA) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001160308, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Savara Inc.'s most comprehensive regulatory disclosure. The most recent Savara Inc. 10-K was filed on 2026-03-13 for fiscal year ending 2026. Historical SVRA 10-K annual reports are available from 2009 through 2026.

Investors researching Savara Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
TNGX SEC Filings →NBTX SEC Filings →TYRA SEC Filings →GHRS SEC Filings →BCAX SEC Filings →EYPT SEC Filings →KURA SEC Filings →GERN SEC Filings →
→ SVRA Financials→ SVRA Earnings→ SVRA Insider Trades

Frequently Asked Questions

SVRA SEC Filings · 8 questions

Savara Inc. (SVRA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Savara Inc.'s CIK is 0001160308.

SVRA SEC filingsSavara Inc. SEC documentsfind SVRA 10-K